Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Blood
|
June 25, 1999
Prothrombotic genetic risk factors in young survivors of myocardial infarction
D Ardissino, P M Mannucci, P A Merlini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 9, 2000
In vivo thrombin generation and activity during and after intravenous infusion of heparin or recombinant hirudin in patients with unstable angina pectoris
P A Merlini, D Ardissino, R D Rosenberg, et al.
Journal of the American Heart Association
|
July 20, 2016
Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50
Stephen K Kidd, Marc P Bonaca, Eugene Braunwald, et al.
Circulation
|
July 22, 2016
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction
Erin A Bohula, Marc P Bonaca, Eugene Braunwald, et al.
Lancet (London, England)
|
August 31, 2012
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
Benjamin M Scirica, Marc P Bonaca, Eugene Braunwald, et al.
ESMO Open
|
August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study
M Nannini, A Rizzo, M C Nigro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma Group
L D'Ambrosio, A Merlini, A Brunello, et al.
Circulation Research
|
May 17, 2017
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease
Akihiro Nomura, Hong-Hee Won, Amit V Khera, et al.
The New England Journal of Medicine
|
November 13, 2014
Inactivating mutations in NPC1L1 and protection from coronary heart disease
, Nathan O Stitziel, Hong-Hee Won, et al.
The New England Journal of Medicine
|
March 3, 2016
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
, Nathan O Stitziel, Kathleen E Stirrups, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Blood
|
June 25, 1999
Prothrombotic genetic risk factors in young survivors of myocardial infarction
D Ardissino, P M Mannucci, P A Merlini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 9, 2000
In vivo thrombin generation and activity during and after intravenous infusion of heparin or recombinant hirudin in patients with unstable angina pectoris
P A Merlini, D Ardissino, R D Rosenberg, et al.
Journal of the American Heart Association
|
July 20, 2016
Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50
Stephen K Kidd, Marc P Bonaca, Eugene Braunwald, et al.
Circulation
|
July 22, 2016
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction
Erin A Bohula, Marc P Bonaca, Eugene Braunwald, et al.
Lancet (London, England)
|
August 31, 2012
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
Benjamin M Scirica, Marc P Bonaca, Eugene Braunwald, et al.
ESMO Open
|
August 5, 2021
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors: a retrospective, multicenter, real-world study
M Nannini, A Rizzo, M C Nigro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 7, 2025
Trabectedin-olaparib combination or trabectedin in advanced soft tissue sarcomas after failure of anthracycline-based treatment (TOMAS2): a randomized phase II study from the Italian Sarcoma Group
L D'Ambrosio, A Merlini, A Brunello, et al.
Circulation Research
|
May 17, 2017
Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart Disease
Akihiro Nomura, Hong-Hee Won, Amit V Khera, et al.
The New England Journal of Medicine
|
November 13, 2014
Inactivating mutations in NPC1L1 and protection from coronary heart disease
, Nathan O Stitziel, Hong-Hee Won, et al.
The New England Journal of Medicine
|
March 3, 2016
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease
, Nathan O Stitziel, Kathleen E Stirrups, et al.
Page
of 9